PR Center

Press Release

Theragen Bio Strengthens Global Leadership with the Inauguration of Baek Soon-myung as New CEO

2024-04-01

Theragen Bio Strengthens Global Leadership with the Inauguration of Baek Soon-myung as New CEO
Theragen Bio, published in the international Article ‘Scientific Reports’ DEEPOMICS® FFPE paper approved for publication

2024-02-01

Theragen Bio, published in the international Article ‘Scientific Reports’ DEEPOMICS® FFPE paper approved for publication
Signed a contract with Theragen Bio Arontier to jointly develop an AI-based personalized cancer vaccine design platform

2024-01-17

Signed a contract with Theragen Bio Arontier to jointly develop an AI-based personalized cancer vaccine design platform
[Press Release]Theragen Bio Achieves 1000th Run with Illumina's 'NovaSeq 6000' S4

2023-12-08

[Press Release]Theragen Bio Achieves 1000th Run with Illumina's 'NovaSeq 6000' S4
[Press Release]Theragen Bio registers a patent for the AI platform DEEPOMICS® NEO for neoantigen vaccine design.

2023-12-06

[Press Release]Theragen Bio registers a patent for the AI platform DEEPOMICS® NEO for neoantigen vaccine design.
[Press Release]Theragen, Element Bioscience Introduce AVITI for the First Time in South Korea

2023-10-13

[Press Release]Theragen, Element Bioscience Introduce AVITI for the First Time in South Korea
[Press Release]Theragen Bio to Strengthen R&D and Advance Digital Healthcare Services through Theragen Health Spin-off

2023-09-12

[Press Release]Theragen Bio to Strengthen R&D and Advance Digital Healthcare Services through Theragen Health Spin-off
[Press Release]Theragen Bio and Korea University Ansan Hospital sign MOU to produce and analyze precision genomic data

2023-07-10

[Press Release]Theragen Bio and Korea University Ansan Hospital sign MOU to produce and analyze precision genomic data
[Press Release]Theragen Bio renews international ISO 27001 and 27701 for 4 years in succession

2023-07-04

[Press Release]Theragen Bio renews international ISO 27001 and 27701 for 4 years in succession

[Press Release]Theragen Bio has obtained a patent for an NGS-based COVID-19 diagnostic and variant determination system for the advancement of infectious disease diagnosis.

2023-05-23

[Press Release]Theragen Bio has obtained a patent for an NGS-based COVID-19 diagnostic and variant determination system for the advancement of infectious disease diagnosis.
[Press Release]Theragen Bio and Agilent Partner to Advance Bioinformatic Solutions for Cancer Genomic Profiling in South Korea

2023-04-26

[Press Release]Theragen Bio and Agilent Partner to Advance Bioinformatic Solutions for Cancer Genomic Profiling in South Korea

[Press Release]Theragen Bio and KAD sign MOU for building a domestic sewer-based monitoring System

2023-04-25

[Press Release]Theragen Bio and KAD sign MOU for building a domestic sewer-based monitoring System
[Press Release]Theragen Bio acquires patent for predicting primary sites of cancer of unknown primary using genomic data.

2023-03-21

[Press Release]Theragen Bio acquires patent for predicting primary sites of cancer of unknown primary using genomic data.
[Press Release]Theragen Bio, registered 8 patents related to genomics analysis and published 21 papers.

2022-12-22

[Press Release]Theragen Bio, registered 8 patents related to genomics analysis and published 21 papers.
[Press Release]Theragen Bio donates cosmetics worth KRW 125 million to underprivileged groups for year-end charity

2022-12-08

[Press Release]Theragen Bio donates cosmetics worth KRW 125 million to underprivileged groups for year-end charity
[Press Release]Theragen Bio and Herbalife Korea launch jointly developed genetic analysis service Gene Start+

2022-08-08

[Press Release]Theragen Bio and Herbalife Korea launch jointly developed genetic analysis service Gene Start+
[Press Release]Theragen Bio renews international standard information security certification ISO 27001 and ISO 27701 for 3 consecutive years ... Demonstrates excellence in personal information protection

2022-07-27

[Press Release]Theragen Bio renews international standard information security certification ISO 27001 and ISO 27701 for 3 consecutive years ... Demonstrates excellence in personal information protection
[Press Release]Theragen Bio selected as the developer of AI software solutions for pediatric rare diseases by the Ministry of Science and ICT's evaluation agency.

2022-07-22

[Press Release]Theragen Bio selected as the developer of AI software solutions for pediatric rare diseases by the Ministry of Science and ICT's evaluation agency.
[Press Release]Theragen Bio Releases The Results of Discovery of The MAST4 Protein, Controlling Bone Cartilage Differentiation Process in Nature Communications, Sister Journal of Nature

2022-07-19

[Press Release]Theragen Bio Releases The Results of Discovery of The MAST4 Protein, Controlling Bone Cartilage Differentiation Process in Nature Communications, Sister Journal of Nature
[Press Release]Theragen Bio and Lotte HealthCare sign investment and strategic partnership agreement for joint healthcare research and new business development.

2022-07-13

[Press Release]Theragen Bio and Lotte HealthCare sign investment and strategic partnership agreement for joint healthcare research and new business development.
[Press Release]Theragen Bio to participate in the 'Korean Chip Genome Information Production Project' led by the Korea Centers for Disease Control and Prevention Agency.

2022-06-07

[Press Release]Theragen Bio to participate in the 'Korean Chip Genome Information Production Project' led by the Korea Centers for Disease Control and Prevention Agency.
Close